INS and type 1 diabetes mellitus: Moreover, a model of IP insulin absorption would be also an important component of in silico platforms, such as the UVa/Padova [14,15], the Cambridge [16] and the AIDA [17] T1D simulators, to develop and test new open- and closed-loop insulin treatment strategies.